DPDonna Parizadeh

Donna Parizadeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Donna Parizadeh has a total of 62 co-authors. Here are the top co-authors by number of shared publications:

  • Farzad Hadaegh

    Prevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran Iran

    9 shared publications
  • Fereidoun Azizi

    Endocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran Iran

    6 shared publications
  • Thien Huynh

    Department of Neurological Surgery and Radiology, Mayo Clinic, Jacksonville, FL (J.R.Z., T.H., R.G.T.).

    5 shared publications
  • Amir Abbas Momenan

    Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, P.O. Box: 19395-4763, Tehran, Iran

    3 shared publications
  • Fereidoun Azizi

    Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    3 shared publications
  • Azra Ramezankhani

    Prevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    2 shared publications

Latest Publications

  • Open Access

    Lateral Decubitus Dynamic CT Myelography with Real-Time Bolus Tracking (dCTM-BT) for Evaluation of CSF-Venous Fistulas: Diagnostic Yield Stratified by Brain Imaging Findings

    by Thien J. Huynh, Donna Parizadeh, Ahmed K. Ahmed, Christopher T. Gandia, Hal C. Davison, John V. Murray, Ian T. Mark, Ajay A. Madhavan, Darya Shlapak, Todd D. Rozen, et al.

    BACKGROUND AND PURPOSE: CSF-venous fistulas (CVFs) associated with spontaneous intracranial hypotension (SIH) may have a transient appearance, relative to contrast arrival, which may influence the diagnostic performance of lateral decubitus CT myelography (CTM). We developed a dynamic CTM protocol using real-time bolus-tracking (dCTM-BT) to improve the temporal resolution and standardize the timing of CTM acquisitions post-intrathecal contrast administration. The purpose of our study was to evaluate the feasibility of the dCTM-BT technique and evaluate its diagnostic yield for CVF detection, stratified by brain MRI SIH findings. MATERIALS AND METHODS: Patients with suspected SIH without extradural fluid collection on spine MRI who underwent dCTM-BT were retrospectively reviewed. CT bolus monitoring was performed at the upper thoracic level. Following the visualization of dense intrathecal contrast, at least 3 CTM acquisitions of the spine were obtained and reviewed by 2 neuroradiologists. The Bern SIH score was calculated on the brain MRI. The diagnostic yield for CVF detection was evaluated, stratified by Bern score categories and a receiver operating characteristic (ROC) analysis. RESULTS: Out of 48 patients, 23 (48%) had a CVF on dCTM-BT, located at T1–5 (n = 4), T6–12 (n = 18), L1 (n = 1), with 70% on the right. CVF was identified in 22/22 (100%) of patients who had a high Bern score, 1/7 (14%) of those who had an intermediate score, and 0/19 (0%) of those who had a low score. The area under the ROC curve was 0.99 (95% CI, 0.98–1.00). The optimal cutoff was a Bern score of ≥5 (96% sensitivity, 100% specificity). CONCLUSIONS: dCTM-BT is feasible and has excellent diagnostic performance for CVF identification/localization. The Bern score is strongly associated with CVF detection and may help inform who will benefit from dCTM-BT.


  • Open Access

    O-034 Characterization of CSF-venous fistula venous drainage patterns and specific site of fistula origin: implications for transvenous embolization

    by T Huynh, D Parizadeh, O Fermo

    Methods A retrospective review of SIH patients who underwent transvenous embolization of CSF-venous fistulas at our institution was reviewed. All patients were diagnosed with SIH based on clinical and/or imaging findings and had a definite diagnosis of CVF on dynamic CT myelogram. Venous drainage patterns were categorized into simple drainage pattern (i.e. draining into the foraminal venous plexus and adjacent segmental vein) and complex drainage pattern (i.e. draining into additional veins including intra-osseous, basivertebral/internal epidural venous plexus, adjacent level, or contralateral level veins). Fistulae origin were first categorized as arising directly from either the nerve root sleeve or adjacent diverticulum and location of origin relative to the sleeve or diverticulum. We also identified the location of the CVF origin relative to the ipsilateral pedicle and neural foramina given that these are common target landmarks to guide embolization. Results Twenty-four CSF-venous fistulae in 23 patients were evaluated. Simple venous drainage pattern was seen in all cases; additional complex venous drainage pattern was visualized in 8 (33%) including 4 cases of intra-osseous venous drainage, 3 cases of adjacent level venous drainage, and 1 level draining to the contralateral side. The origin of the CVF was visualized in 23/24 (96%) of cases and was seen originating directly from the diverticulum in 15 (65%) and from the nerve root sleeve in 8 (35%). The CVF origin was located in the anterior neural foramina inferior to the pedicle in 14 (61%) and lateral to the pedicle/foramina in 9 (39%). Conclusion CVF have varied venous drainage patterns which may have implications for both transvenous microcatheter navigation and embolization planning. Microcatheter positioning and embolization immediately under or just lateral to the pedicle and neural foramina is an ideal location to ensure occlusion of CVF origin in most cases. Example of complex CSF-venous fistula drainage pattern including drainage into the basivertebral vein, intra-osseous, and dorsal muscular venous branches. The fistula originates directly from the nerve root sleeve without a significant diverticulum present Disclosures T. Huynh: None. D. Parizadeh: None. O. Fermo: None.

  • Open Access

    O-032 Transvenous embolization of cerebrospinal fluid-venous fistulas: long-term clinical and imaging outcomes

    by D Parizadeh, O Fermo, K Brewer, T Huynh

    Introduction With promising reports of the short-term outcomes of endovascular transvenous embolization, this technique is now recognized as a highly efficient and safe treatment for patients with spontaneous intracranial hypotension (SIH) secondary to CSF-venous fistulas (CVF). Long-term efficacy beyond 3 months remains poorly described in the literature. We sought to investigate the one-year imaging and clinical outcomes of this procedure. Methods A retrospective review of patients who underwent transvenous embolization of CSF-venous fistulas at our institution was reviewed. Patients treated between December 2020 and March 2023 were included. All patients were diagnosed with SIH based on clinical and/or imaging findings and had a definite diagnosis of CVF on lateral decubitus digital subtraction or dynamic CT myelogram. Pre-and long-term, 1-year, post-embolization clinical evaluation and brain MRI findings including the Bern SIH score were recorded and long-term post-procedural complications were reviewed. Results During the study period, 18 patients underwent the procedure. Long-term follow-up was available for 13 patients, with median (IQR) age 61 (50 - 65) years and 62% female. Median (IQR) follow-up was 12 (10-13) months for clinical (available for 13/13 patients) and 11 (7-13) months for imaging outcomes, available for 13 and 10 patients, respectively. 10/13 (77%) patients had sustained clinical improvement, 2/13 (15%) had recurrence of symptoms due to a new leak from a new site (n = 1) or the previously embolized site (n = 1), and 1/13 (8%) did not respond to treatment. Patients also had sustained imaging improvement with a pre-embolization median (IQR) Bern SIH score of 7 (8-8) improving to 2.5 (3-4) at 3-month and 1.5 (2-3) at 1-year follow-up. There were no long-term complications. Short-term side effects were localized back pain (76%) and rebound headache (46%) which resolved in the long-term follow-up for all patients. Conclusion Transvenous embolization has high efficacy and safety in the long-term and can be considered a durable treatment for SIH patients with CVF. A small proportion of patients may however develop new leaks which require further evaluation and treatment. Imaging of a patient in their 40s diagnosed spontaneous intracranial hypotension before and after transvenous embolization of a CSF-venous fistula (CVF) at right T10. Pre-embolization sagittal T1-weighted MRI (A) shows severe midbrain sagging and low-lying cerebellar tonsils before embolization of CVF at right T10 (B) Short-term follow-up MRI at 3-months (C) and long-term follow-up MRI at 13 months (D) show sustained improvement of imaging findings which was concordant with sustained resolution of symptoms Disclosures D. Parizadeh: None. O. Fermo: None. K. Brewer: None. T. Huynh: None.

  • Transvenous embolization of cerebrospinal fluid-venous fistulas: Independent validation and feasibility of upper-extremity approach and using dual-microcatheter and balloon pressure cooker technique

    by Donna Parizadeh, Olga Fermo, Prasanna Vibhute, Vivek Gupta, Jorge L Arturo Larco, Sanjeet S Grewal, Alfredo Quinones-Hinojosa, Young M Erben, Steven Clendenen, Todd D Rozen, et al.

    Background: Transvenous embolization is emerging as a promising treatment for cerebrospinal fluid-venous fistulas (CVF) associated with spontaneous intracranial hypotension (SIH). Objective: To perform an independent validation of the efficacy and safety of the procedure and describe the procedural techniques used at our institution. Methods: A retrospective review was performed including consecutive patients with SIH who had undergone CVF embolization with 3-month clinical and imaging follow-up. Clinical evaluation included the Patient Global Impression of Change (PGIC) Scale and six-item Headache Impact Test (HIT-6). Bern SIH score was used for imaging evaluation on brain MRI. Post-treatment changes in scores were assessed by Wilcoxon signed rank test. Procedural technical details, including use of upper-extremity access and dual-microcatheter pressure cooker technique, were recorded. Results: 18 patients (13 female, median age 60 years) were included. 17 (94%) procedures were performed with upper-extremity access and 12 (67%) using dual-microcatheter pressure cooker technique. After embolization, 16 (89%) patients reported much or very much improved at follow-up PGIC; median (IQR) HIT-6 score improved from 68 (62–72) to 36 (36–38) and Bern SIH score improved from 8 (6–8) to 3 (1.5–3.5), p values 0.05). Conclusion: Transvenous embolization is independently validated as a highly effective and safe treatment for CVF and is feasible using upper-extremity venous access. Dual-microcatheter and balloon/coil pressure cooker techniques may be used to optimize distribution of embolic material and potentially, treatment efficacy.


  • Dual microcatheter and coil/balloon pressure cooker technique for transvenous embolization of cerebrospinal fluid-venous fistulas

    by Donna Parizadeh, Antonio H C Vasconcelos, David A Miller, Olga P Fermo, Thien J Huynh

    Cerebrospinal fluid-venous fistula is increasingly recognized as a cause of spontaneous intracranial hypotension.1 Transvenous embolization is emerging as an efficacious minimally invasive treatment.2–4 The procedure aims to embolize paraspinal and foraminal veins draining the fistula; however, complete embolization may be challenging as numerous small venous tributaries at the foraminal venous plexus, including dorsal muscular branches, may serve as additional routes of cerebrospinal fluid egress.5 To ensure curative embolization, we adopted a dual microcatheter pressure cooker technique, previously used for treatment of brain arteriovenous malformations.6 This allows improved control of embolic material reflux and greater chance of complete embolization of the site of the fistula and all potential venous tributaries. Video 1 demonstrates this technique employed in a typical case using Onyx (Medtronic, Minnesota, USA) to embolize a cerebrospinal fluid-venous fistula at the left L1 neural foramen. Video 1 Technical video demonstrating dual-microcatheter and coil/balloon pressure cooker technique.:


  • Open Access

    Diabetes, Hypertension, and Incidence of Chronic Kidney Disease: Is There any Multiplicative or Additive Interaction?

    by Saeed Erfanpoor, Koorosh Etemad, Sara Kazempour, Farzad Hadaegh, Jalil Hasani, Fereidoun Azizi, Donna Parizadeh, Davood Khalili

    Background: The burden of chronic kidney disease (CKD) is on the rise worldwide; diabetes and hypertension are mentioned as the main contributors. Objectives: The current study aimed to investigate the multiplicative and additive interaction of diabetes and hypertension in the incidence of CKD. Methods: In this population-based cohort study, 7342 subjects aged 20 years or above (46.8% male) were divided into four groups: no diabetes and hypertension; diabetes and no hypertension; hypertension and no diabetes; and both diabetes and hypertension. The multivariable Cox regression was used to determine the effect of diabetes, hypertension, and their multiplicative interaction on CKD. The following indices were used to determine the additive interaction of diabetes and hypertension: the relative excess risk of interaction, the attributable proportion due to interaction, and the synergism index. Results: Diabetes and hypertension had no significant multiplicative interaction in men (hazard ratio of 0.93, P value: 0.764) and women (hazard ratio of 0.79, P value: 0.198); furthermore, no additive interaction was found in men (relative excess risk due to interaction of 0.79, P value: 0.199; attributable proportion due to interaction of 0.22, P value: 0.130; synergy index of 1.44, P value: 0.183) and women (relative excess risk due to interaction of -0.26, P value: 0.233, attributable proportion due to interaction of -0.21, P value: 0.266; synergy index of 0.48, P value: 0.254). Conclusions: This study demonstrated no synergic effect between diabetes and hypertension on the incidence of CKD.


  • Metabolic health in the Middle East and north Africa

    by Fereidoun Azizi, Farzad Hadaegh, Farhad Hosseinpanah, Parvin Mirmiran, Atieh Amouzegar, Hengameh Abdi, Golaleh Asghari, Donna Parizadeh, Seyed Ali Montazeri, Mojtaba Lotfaliany, et al.


  • Sex-specific initiation rates of tobacco smoking and its determinants among adults from a Middle Eastern population: a cohort study

    by Donna Parizadeh, Seyyed Saeed Moazzeni, Mitra Hasheminia, Pegah Khaloo, Mohammad Ali Mansournia, Fereidoun Azizi, Amir Abbas Momenan, Farzad Hadaegh

    To assess the initiation rate and determinants of tobacco smoking among adults.


  • Impaired fasting glucose prevalence surge among Iranian adolescents in a decade: The Tehran Lipid and Glucose Study

    by Vahid Eidkhani, Donna Parizadeh, Mitra Hasheminia, Fereidoun Azizi, Farzad Hadaegh

    Purpose Impaired fasting glucose (IFG) is associated with incident diabetes, cardiovascular risk, and markers of atherosclerosis in early adulthood. We aimed to explore the 10‐year change in IFG prevalence among adolescent participants of the Tehran Lipid and Glucose Study, a population‐based study from Iran. Methods For our study, we used data on fasting plasma glucose (FPG), anthropometric and demographic information of 11‐19 year‐old adolescents in study period I (1999‐2005; 1415 boys, 1583 girls) and study period II (2011‐2014; 477 boys, 469 girls). Sex‐adjusted and sex‐stratified multivariable logistic regression models were used to assess the relationship of the study period (reference: study period I) with IFG. Results The prevalence of IFG, general obesity, and central obesity increased from 7%, 13.3%, and 18.8% in study period I to 16.6%, 24%, and 37.4% in study period II; while a favorable trend was seen for blood pressure, triglycerides and high density lipoprotein cholesterol. In the fully adjusted model, being older (age group 15‐19 vs 11‐14 years) and female sex were associated with lower risk. Being overweight and obese increased the risk by risk ratios (confidence interval) of 1.57 (1.17‐2.11) and 1.63 (1.15‐2.30), respectively. Central adiposity did not remain as an independent risk factor. Nevertheless, study period persisted as a significant factor despite all adjustments [2.20 (1.81‐2.68)]. Results in the sex‐stratified models were generally the same. Conclusion Our results demonstrated that the over 2‐fold rise in IFG prevalence among adolescents was not solely dependent on general and central obesity.


  • Open Access

    Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study

    by Donna Parizadeh, Neda Rahimian, Samaneh Akbarpour, Fereidoun Azizi, Farzad Hadaegh

    Aims: To investigate the sex-specific associations of prediabetes with major clinical outcomes including incident type 2 diabetes, chronic kidney disease, hypertension, coronary heart disease, stroke and all-cause mortality.Methods: Among 8498 Iranian adults from the Tehran Lipid and Glucose Study, aged ≥30 years and without diagnosed type 2 diabetes, gender-interactions were assessed for each outcome, followed by sex-separated multivariate-adjusted Cox proportional hazard models to calculate hazard ratios and 95% confidence intervals (CIs) of different prediabetes categories, including impaired fasting glucose (IFG), defined by the American Diabetes Association (ADA) and World Health Organization (WHO), as fasting plasma glucose of 5.6–6.9 mmol/L and 6.1–6.9 mmol/L, respectively, and impaired glucose tolerance, defined as 2-h post challenge plasma glucose of 7.8–11 mmol/L.Results: Sex-specific associations existed for men between IFG-ADA and chronic kidney disease (hazard ratio: 1.28, 95% CI 0.99–1.65; pinteraction = 0.008) and between IFG-WHO and stroke (hazard ratio: 2.15, 95% CI 1.08–4.27; pinteraction = 0.21); and for women between IFG-ADA and hypertension (hazard ratio: 1.24, 95% CI 1.04–1.48; pinteraction = 0.06) and between impaired glucose tolerance and coronary heart disease (hazard ratio: 1.57, 95% CI 1.14–2.16; pinteraction = 0.05). Among both genders, all prediabetes definitions were associated with type 2 diabetes but none with mortality.Conclusions: The hazards of prediabetes definitions may differ between genders depending on the outcome of interest. IFG-WHO among men and impaired glucose tolerance among women are particularly important because of their association with incident stroke and coronary heart disease, respectively. Considering these sex differences could improve personalized management of prediabetes.